RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 6.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $93,000 | -57.3% | 78,462 | +23.2% | 0.01% | -64.0% |
| Q1 2021 | $218,000 | +53.5% | 63,679 | -17.7% | 0.02% | +19.0% |
| Q2 2020 | $142,000 | +84.4% | 77,390 | +161.8% | 0.02% | +61.5% |
| Q2 2019 | $77,000 | -36.4% | 29,562 | -37.1% | 0.01% | -35.0% |
| Q1 2019 | $121,000 | +45.8% | 47,031 | +30.9% | 0.02% | +42.9% |
| Q4 2018 | $83,000 | 0.0% | 35,939 | +39.1% | 0.01% | +16.7% |
| Q3 2018 | $83,000 | +66.0% | 25,843 | +48.5% | 0.01% | +50.0% |
| Q2 2018 | $50,000 | +28.2% | 17,402 | +11.1% | 0.01% | -38.5% |
| Q3 2015 | $39,000 | -59.4% | 15,668 | -40.2% | 0.01% | -68.3% |
| Q1 2015 | $96,000 | – | 26,209 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |